Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which heart device lead lasts longest in kids? study aims to find out

NCT ID NCT00335036

Terminated Disease control Sponsor: Charles Berul Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two types of implantable cardioverter defibrillator (ICD) leads in children and patients with congenital heart disease. The goal was to see which lead type lasts longer without breaking and is easier to remove if needed. The trial was terminated early, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
implantable cardioverter defibrillator (ICD) leads
What this could lead to
If successful, this study could help doctors choose better ICD leads for children and heart disease patients, reducing the need for risky removal procedures.
What could go wrong
The study was terminated early, so results may be incomplete. It is also observational in nature, so it cannot prove that one lead type is definitively better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy congenital heart disease Death, Sudden, Cardiac long QT syndrome ventricular fibrillation ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMYOPATHY CONGENITAL HEART DISEASE LONG QT SYNDROME VENTRICULAR FIBRILLATION VENTRICULAR TACHYCARDIA

Contacts and locations

Locations

  • Children's Hospital Boston

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.